Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction

Cohen, L. P., Isaza, N., Hernandez, I., Lewis, G. D., Ho, J. E., Fonarow, G. C., Kazi, D. S., & Bellows, B. K. (2023). Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. JAMA Cardiology, 8(5), 419. https://doi.org/10.1001/jamacardio.2023.0077
Authors:
Laura Cohen
Nicolás Isaza
Inmaculada Hernandez
Gregory D. Lewis
Jennifer E. Ho
Gregg C. Fonarow
Dhruv S. Kazi
Brandon K. Bellows
Affiliated Authors:
Laura Cohen
Brandon K. Bellows
Columbia Affiliation:
Subjects:
Heart Failure (MeSH)
Sodium-Glucose Transporter 2 Inhibitors (MeSH)
Management of Diabetes Mellitus and Cardiovascular Risk (OpenAlex Topic)
Diagnosis and Treatment of Heart Failure (OpenAlex Topic)
Management of Hyperkalemia in Kidney Diseases (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1001/jamacardio.2023.0077
PMID:
36870047
DOI:
10.1001/jamacardio.2023.0077
Journal:
JAMA Cardiology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: